Adding tirofiban to therapy with clopidogrel, aspirin, and heparin while the patient is in transit to a PCI center improves ST-segment resolution; outcomes may also improve, the trial hinted. Heartwire
Early research suggests the potential anticancer therapeutics might be especially risky for patients with prior or ongoing heart disease. Medscape Medical News
Is cardiovascular care poised to enter the brave new world of pharmacogenomics? A test for a pair of genetic markers seems to distinguish heart-failure patients who are likely or unlikely to respond to a beta blocker now under FDA review. Heartwire
Poor exercise capacity is linked with an increased risk for myocardial infarction, unstable angina, coronary revascularization, and mortality among patients referred for exercise treadmill testing. Medscape Medical News
